P/E ratio for Kamada (KMDA)
P/E ratio as of April 2024 (TTM): 64.0
According to Kamada 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 64. At the end of 2022 the company had a P/E ratio of -80.2.
P/E ratio history for Kamada from 2013 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -80.2 | -39.06% |
| 2021 | -132 | -932.65% |
| 2020 | 15.8 | 24.96% |
| 2019 | 12.6 | 39.13% |
| 2018 | 9.09 | -67.46% |
| 2017 | 27.9 | -192.28% |
| 2016 | -30.3 | 126.17% |
| 2015 | -13.4 | 26.83% |
| 2014 | -10.6 | -95.84% |
| 2013 | -254 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | 30.4 | -52.57% | 🇺🇸 USA |
 Compugen CGEN | -4.90 | -107.66% | 🇮🇱 Israel |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.